PathAI, Inc., a global leader in artificial intelligence (AI)-powered pathology solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation ...
Medical Device Network on MSN
FDA grants breakthrough designation to PathAI for pathology solution
The latest milestone follows PathAI’s 510(k) clearance for AISight Dx, the first FDA-approved digital pathology system.
CLEVELAND, March 10, 2026 /PRNewswire/ -- GenomOncology, a leading precision medicine software company, today announced a strategic partnership with WeTrials, an AI-powered patient engagement and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果